Koninklijke Philips N.V.
Company Snapshot
Company Overview
Koninklijke Philips N.V. is a global health technology company. The company markets products in the following categories: mother and childcare; oral healthcare; male grooming and beauty; kitchen appliance; coffee, air, garment care and floor care products; and sleep, respiratory care and respiratory drug delivery products.
Philips has taken a leadership position in integrating liquid biopsy with imaging for cancer applications. Philips leads the LIMA consortium.
The Liquid Biopsies and Imaging for Improved Cancer Care initiative is being funded by the European Commission’s Horizon 2020 Research and Innovative Framework program. This is a four-year project (2018-2022) to increase the accuracy of both the genetic and functional characterization of primary breast and rectal cancer.
The project is evaluating technologies for analyzing CTC DNA from Agena Bioscience, DiaDx and Stilla Technologies; Angle’s Parsortix system for CTC isolation; and instruments for single CTC detection and selection by ALS Automated Lab Solutions. Royal Philips provides advanced magnetic resonance imaging (MRI) tools.
Financial Highlights (FY 2023)
This information is available for BCC Research members only.
Company's Business Segments
- Diagnosis & Treatment : Precision Diagnosis and Image Guided Therapy.
- Connected Care : Monitoring, Sleep & Respiratory Care, and Enterprise Informatics.
- Personal Health : Personal Health
- Other
Applications/End User Industries
- Cardiology
- Peripheral Vascular
- Neurology
- Surgery
- Oncology
